1,127 search results for “cancer drug discovery initiative” in the Staff website
-
Discovery and characterization of new glucosylated metabolites
PhD defence
-
Discovery of selective diacylglycerol lipase β inhibitors
PhD defence
-
Peter ten DijkeFaculteit Geneeskunde
p.ten_dijke@lumc.nl | +31 71 526 9270
-
‘Pharmacogenetics will become part of patient care’
Does medicine make patients feel better or worse? We are getting better at predicting this from people’s DNA profiles, says Professor Jesse Swen. ‘It never fails to fascinate me how one DNA base pair can have such a huge effect on treatment with medication and the outcome.’
-
Meet Prof. dr. Jürgen K. Zangenberg, LJSA Co-Initiator and Member
Prof. Zangenberg came to Leiden in 2006 as Professor for New Testament and Early Christian Literature and is now Chair for the History and Culture of Ancient Judaism and Early Christianity.
-
Review on “Anticancer opportunities at every stage of chemokine function” is featured on the cover of TIPS
Last November, Dr. Natalia Ortiz, Martijn Bemelmans (MSc), and Prof. Laura Heitman published a review in Trends in Pharmacological Sciences (TIPS) on targeting the chemokine system in cancer (https://doi.org/10.1016/j.tips.2021.08.001). The review was written in collaboration with Prof. Tracy Handel…
-
Training: alcohol and drug use among students
Training for staff members
-
Training: alcohol- and drug use under students
Training for staff members
-
Selective cannabinoid CB2 receptor activation in Nature Communications
This March, Jara Bouma, Cas van der Horst and Laura Heitman from the Division of Drug Discovery and Safety and Laura de Paus, Richard van den Berg, Anthe Janssen and Mario van der Stelt from the LIC joined forces to determine how some drugs can specifically target the cannabinoid CB2 receptor (CB2R)…
-
During the next pandemic, this mathematical model will speed up the search for treatment
Do you recall all those drugs that were hastily proposed as potential treatments for COVID-19? In the event of a future pandemic, the goal is to offer an effective treatment more quickly and efficiently. To achieve this, a team led by Coen van Hasselt is developing a platform that can speed up the process…
-
Medical Delta AI for Computational Life Sciences
The fact that scientists are increasingly better able to access molecular cell and tissue data also brings with it a new challenge: how can scientists find the information they need for research among the vast amount of data available?
-
Inexhaustible source of human heart muscle cells allows strong reduction of animal testing
Researchers at the Leiden University Medical Centre (LUMC) have managed to culture human heart muscle cells on a massive scale. This is an exceptional achievement because it is very difficult to replicate heart muscle cells outside the body. Using a special technique, the researchers have now created…
-
‘Using real-world data to enhance our healthcare system’
On 16 May 2022, Professor Michel Wouters from the Department of Biomedical Data Sciences at the Leiden University Medical Centre (LUMC), will deliver his inaugural lecture titled ‘Quality of Cancer Care: why the real world matters’. Wouters will use the opportunity to describe how quality registries…
-
T-cells more important in the fight against the COVID-19 virus than initially thought
A COVID-19 vaccine that specifically instructs the immune system to produce T-cells rather than antibodies is shown to provide good protection in a mouse model, Leiden University Medical Center (LUMC) researchers report in Nature Communications. According to them, the alternative vaccine may offer a…
-
Holger HoosFaculty of Science
h.h.hoos@liacs.leidenuniv.nl | +31 71 527 5777
-
Nasi LiuFaculty of Science
n.s.liu@lacdr.leidenuniv.nl | 071 5276225
-
Marjolijn LugthartFaculty of Science
m.j.l.lugthart@lacdr.leidenuniv.nl | +31 71 527 6270
-
Dario BijkerFaculty of Science
d.i.bijker@lacdr.leidenuniv.nl | +31 71 527 2727
-
Martijn MonéFaculty of Science
m.j.mone@lacdr.leidenuniv.nl | 071 5276105
-
Pharma-NL application submitted to National Growth Fund
The Ministry of Health, Welfare and Sport (VWS) submitted Pharma-NL to the R&D program of the National Growth Fund, a 20 billion euro program of the Dutch government that intends to create long-term economic growth in The Netherlands.
-
Ian ShenFaculty of Science
z.shen@liacs.leidenuniv.nl | 071 5272727
-
Chemistry as the key to medical innovation
Is it a coincidence that three chemists from the same department have each independently received a ZonMw grant? 'No,' the researchers agree in unison. 'The role of chemistry in medical biology is becoming increasingly important, and we’ve worked hard to make this happen.'
-
Proof of Concept grants for four Leiden researchers
Four Leiden researchers have been awarded Proof of Concept grants by the ERC. These grants, each worth 150,000 euros, help researchers translate the findings of previous ERC projects into innovative practical applications.
-
Serkan AslanFaculty of Science
s.aslan@lacdr.leidenuniv.nl | 071 5275919
-
Rob van WijkFaculty of Science
r.c.van.wijk@lacdr.leidenuniv.nl | +31 71 527 4505
-
Let the robot lend a hand in the pharmacy (it’s more sustainable too)
Can a robot help prepare cancer medication in a hospital pharmacy? That’s what hospital pharmacist Tjerk Geersing investigated in his PhD research. He compared manual and automated preparations in terms of quality, efficiency, and safety. He graduated on 19 March.
-
Patient-derived models of breast cancer: A breakthrough story of the duct
PhD defence
-
Disrupting the transcriptional machinery to combat triple-negative breast cancer
PhD defence
-
BRCA1-associated breast cancer: finding new weapons for an old villain
PhD defence
-
Multifaceted Roles of Grainyhead-like Transcription Factor- 2 in Breast Cancer
PhD defence
-
Building a greener future at Leiden University in 2025
From a vegan community kitchen to a green framework for drug development: sustainability became more visible in everyday campus life at Leiden University in 2025.
-
Antibiotic Discovery: From mechanistic studies to target ID
PhD defence
-
Harnessing zebrafish xenograft models for ocular melanoma treatment discovery
PhD defence
-
Four NWO Open Competition grants for Leiden researchers
Four researchers from Leiden University have been awarded NWO Open Competition grants in the Science domain. This is for research into subjects such as immune cells in tumours, antibiotic resistance and magnetic semiconductors.
-
Joost BatenburgFaculty of Science
k.j.batenburg@liacs.leidenuniv.nl | 071 5276985
-
Life after the Grand Jamboree: Wrapping-up iGEM
‘A challenging rollercoaster, but also a very bonding and insightful experience,’ that’s how the team of iGEM Leiden 2022 wraps up their participation in the iGEM contest. The contest for synthetic biology climaxed during the Grand Jamboree in Paris. The team ended up in the top 10 of over 360 teams…
-
Serena VitiFaculty of Science
viti@strw.leidenuniv.nl | +31 71 527 5803
-
Anke HaarmannFaculty of Humanities
a.haarmann@hum.leidenuniv.nl | 071 5272727
-
Nature Communications paper on therapeutic melanoma inhibition by local micelle-mediated cyclic nucleotide repression
Cancer immunotherapy represents a significant breakthrough in cancer treatment. However, tumors have numerous mechanisms by which they evade destruction by the immune system. It is therefore necessary to decipher and reverse these mechanisms in order to improve immunotherapies.
-
John HaanenFaculteit Geneeskunde
j.haanen@nki.nl | +31 71 526 3057
-
Rick HaasFaculteit Geneeskunde
r.l.m.haas@lumc.nl | +31 71 526 9111
-
Eveline BleikerFaculteit Geneeskunde
e.bleiker@nki.nl | +31 71 526 8033
-
From data to discoveries: machine learning and optimization in space
Lecture
-
LACDR EMA Lunchtalk
On Friday the 29th of October, LACDR presented highlights of its research and teaching program during an online Lunchtime Talk session at the European Medicines Agency (EMA).
-
ULLA workshop – summer school - courses
We are proud partner of the ULLA. It is the European University Consortium for Pharmaceutical Sciences in which LACDR participates for already 30 years. We have the honor to host the ULLA workshop in 2023 and the ULLA summer school in 2024.
-
Tamara Danilyuk wins the EUROTOX 2023 Early Career Award
I am thrilled to share the exciting news of being honored with the 2023 Early Career Award at the EUROTOX conference held in Ljubljana, Slovenia. This recognition, presented by ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals) and dedicated to the memory of Dr. Christa Hennes, holds…
-
Grants for fundamental research in Leiden
Three fundamental research projects at Leiden in physics, chemistry and medical science have received funding from the Dutch Research Council (NWO). They involve research on magnetic fields in the universe, the role of myeloid cells in cancer immunotherapy and the evolution of ancient proteins.
-
Popular science events
Every year Leiden University organises a number of events where our researchers share their knowledge with an audience of all ages. We are also involved as a partner in a number of local and national events. Fancy joining in? See who to contact below.
-
James HardwickFaculteit Geneeskunde
j.c.h.hardwick@lumc.nl | +31 71 526 5364
-
Maarten VermeerFaculteit Geneeskunde
m.h.vermeer@lumc.nl | +31 71 526 1952